Meta: Accelerating Research on Rare Diseases

March 19, 2021 | Meta | By Jennifer L. Minnick “At a recent workshop about Meta, Executive Director of Cure HHT Marianne Clancy noticed a new scientific paper about the rare disease she’s focused on curing — in the form of a case report from Sudan. Hereditary Hemorrhagic Telangiectasia, or HHT, is a genetic disorder that causes…

Learn More >>

Las Guías Internacionales de HHT: Anemia (Recorded)

Las Guías Internacionales de HHT Anemia 27 de Marzo | 9:00 a.m. (ET) (10 a.m. Argentina) El Dr. Marcelo Serra, médico internista y Director de la Unidad HHT, Hospital Italiano de Buenos Aires (Centro de Referencia) y la Dra. Yesica Lijdens (Otorrinolaringologa de la Unidad HHT Hospital Italiano de Buenos Aires) nos brindarán información sobre…

Learn More >>

International HHT Guidelines: GI Bleeding Management (Recorded)

International HHT Guidelines Webinar Series Dr. Murali Chakinala, Co-Director, Washington University HHT Center of Excellence and Dr. Vivek Iyer, Director, Mayo Clinic HHT Center of Excellence as they discuss how to recognize the signs and symptoms of GI bleeding in HHT. Drs. Chakinala and Iyer will further dissect this subject area by taking the audience…

Learn More >>
Meta Blog

Meta: Accelerating Research on Rare Diseases

Guidelines Series - 6 - Anemia (espanol)

Las Guías Internacionales de HHT: Anemia (Recorded)

Guidelines Webinar Series - 3 - GI Bleeding

International HHT Guidelines: GI Bleeding Management (Recorded)

Zebra Landscape_web_box

Lift Your Heart for HHT Celebration Kickoff!

HHT-Ireland-Women-in-Science250 - McLoughlin

Women in Science Day 2021 – International

Card1_Cure HHT and RDD Branded

Rare Disease Month

PATH_Logo

PATH – Now Recruiting!

Washington DC_Victory

A WIN on Capitol Hill for HHT!

Find Support

Connect with the Cure HHT community and find the latest resources including treatment centers, patient conferences, webinars and more.

Research for a Cure

Thanks to our supporters we're making exciting strides - gaining new insights into the cause, development and progression of this disease.

Who We Are

Constantly working for a brighter future for those with HHT through awareness, education and research - Cure HHT is the cornerstone of the HHT Community.

International HHT Guidelines

EXPLORE RECOMMENDATIONS BY TOPIC AREA, VIEW CUSTOM CARE CHECKLISTS, AND MUCH MORE.

Find the most up-to-date resources to manage your HHT.

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu Syndrome, is an inherited disease that leads to malformed blood vessels in multiple organs of the body and typically begins with nosebleeds during childhood. HHT can result in serious health problems if not promptly diagnosed and treated. Our mission is to find a cure for HHT while saving the lives and improving the well-being of individuals and families affected by HHT.

1 in
Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder of the blood vessels that affects approximately 1 in 5,000 people worldwide.
%
of people with HHT are undiagnosed